Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
Clinical trial NCT05105100 · COMPLETED
Trial details
- NCT number
- NCT05105100
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-10-29
- Primary completion
- 2025-09-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.